logo Click here for the Chao Family Comprehensive Cancer Center Home Page Click here for the UC Irvine Home Page

Dr. Violet Shen is the new director of the Clinical Research Office

Dr. Violet Shen has been appointed Director of the Clinical Research Office at the UC Irvine Chao Family Comprehensive Cancer Center (CFCCC).  She will serve as a liaison between Center Investigators, CFCCC Research Administration and various University entities and the community.  The focus of her Directorship will be to enhance translational oncology research at UCI and to support HDII protocol development through continuous evaluation of our protocol portfolio, and continuous assessment of health needs of our community.  Dr. Shen joined UCI as an Associate Clinical Professor WOS in the Department of Pediatrics with the amalgamation of UCI & CHOC, and will be appointed as a Member in the Chemical & Structural Biology Research Program.

"We are delighted to announce Violet Shen as the Director of our Clinical Research Office," said Frank Meyskens, MD, Director of the Chao Family Comprehensive Cancer Center. "Dr. Shen brings exceptional experience and a dedication to oncology research and patient care to this important position within the CFCCC."

Dr. Shen earned her medical degree from National Taiwan University, College of Medicine and did her internship in Pediatrics at St. Vincent’s Hospital and Medical Center in New York. She went on to do her residency in Pediatrics at Cornell Medical College-North Shore University Hospital and her fellowship in Pediatric Hematology/Oncology at Cornell Medical College-New York Hospital and Memorial Sloan-Kettering Cancer Center. She is a board certified Pediatrician and Pediatric Hematologist/Oncologist.  She is currently leading-the-way for CHOC’s cancer research as the Principal Investigator for the Children’s Oncology Group (COG) studies, and the Children’s Cancer Group (CCG) phase I research programs, and the COG phase I consortium. CHOC Children's Cancer Institute has been designated as a Phase I clinical trial facility by the Children’s Oncology Group (COG), the nation’s predominant clinical trials group for children and young adult patients with cancer. Dr. Shen has expertise in treatment of pediatric brain tumors, and is also Director of the Pediatric Neuro-Oncology Program and manages the Neuro Oncology Clinic at the Hyundai Cancer Institute Clinic at CHOC.

The CFCCC would like to thank Dr. David Hsiang, M.D., for his tremendous efforts and achievements during his tenure as CRO Director.  He has served as the Clinical Research Office Director since 2005.   He was extremely helpful with his significant experience in patient-oriented cancer research and associated regulatory issues.  He was appointed Cancer Liaison Officer for the Chao Family Comprehensive Cancer Center (Commission on Cancer Program) representing the American College of Surgeon during his tenure, and was also Co-PI of a multi-center nationwide study involving optical laser measurements in breast cancer.  Dr. Hsiang served as the Chair for the Clinical Research Advisory Council while also providing scientific consulting expertise and direction for the CRO. 

The Clinical Research Office (CRO) coordinates the activities and provides oversight for cancer clinical research studies conducted at the Chao Family Comprehensive Cancer Center. The CRO is physically located on the fourth floor of the Clinical Cancer Center and in the Cancer Center Administrative Complex. It is made up of four units: the Therapeutics Research Office (TRO), the Prevention Research Office (PRO), the Regulatory Affairs Office (RAO), and the Recruitment Office (RO). In addition, the CRO works closely with two other units, Clinical Informatics and the Business Office, in overall protocol development and management. The CRO works with the senior leaders, program leaders and investigators to prioritize and coordinate clinical trials, aiming to achieve an adequate protocol portfolio to meet the needs of the Cancer Center patient population and the clinical focus of Cancer Center Members. 

Please join us in welcoming Violet Shen who will start her new position on October 1st, and in thanking David Hsiang for his service.

More information on the CFCCC’s Clinical Research Office is available at http://www.cancer.uci.edu/resources/clinical_research_office.html.